Marta Davilla

Suggest Changes
We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
2534 Background: We have initiated phase I clinical trials treating patients with chemotherapy-refractory chronic lymphocytic leukemia (CLL) (IRB #06-138) and relapsed acute lymphoblastic leukemia(More)
  • 1